Patents
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/1999
10/14/1999WO1999051640A1 Human oxidized ldl receptor
10/14/1999WO1999051596A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051595A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051284A2 Non-covalent bioconjugates useful for diagnosis and therapy
10/14/1999WO1999051275A2 Mesenchymal stem cells as immunosuppressants
10/14/1999WO1999051270A1 A novel nitroreductase and therapeutic uses therefor
10/14/1999WO1999051260A2 Treatment of cardiac hypertrophy
10/14/1999WO1999051248A1 New combined preparation for the treatment of neoplasic diseases or of infectious diseases
10/14/1999WO1999051243A1 THE USE OF ESTRADIOL DERIVATIVES FOR TREATING SIDE-EFFECTS DURING AND/OR AFTER GnRHa THERAPY
10/14/1999WO1999051236A1 Methods for inhibiting mrp1
10/14/1999WO1999051233A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051232A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051231A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051228A1 Methods for inhibiting mrp1
10/14/1999WO1999051227A1 Methods for inhibiting mrp1
10/14/1999WO1999051225A1 Antidiabetic agents
10/14/1999WO1999051220A1 Methods and compositions for reducing uv-induced inhibition of collagen synthesis in human skin
10/14/1999WO1999051217A1 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof
10/14/1999WO1999051215A2 Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins
10/14/1999WO1999051186A2 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/14/1999WO1999051185A2 Human galactosyl transferases
10/14/1999WO1999051097A1 Compositions containing a combination of a creatine compound and a second agent
10/14/1999WO1999044628A8 Conjugates useful in the treatment of prostate cancer
10/14/1999WO1999044623A8 Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid
10/14/1999WO1999043809A3 Protease-activated receptor 4 and uses thereof
10/14/1999WO1999043332A8 Antitumor combination comprising epirubicin and gemcitabine for the treatment of non-small-cell lung cancer
10/14/1999WO1999042579A3 Caf1-related protein
10/14/1999WO1999039702A3 Method for regulating size and growth of vascularized normal tissue
10/14/1999WO1999031225A3 Human phosphatases
10/14/1999WO1999026660A3 Conjugates of cytokines and drugs or genes for treating proliferating cells
10/14/1999DE19913089A1 Composition comprising plant extracts from at least two of Bryonia, Ipecacuanha or Drosera, and antimony potassium tartrate, useful for treatment of chronic obstructive pulmonary disease, bronchitis, respiratory disorders and cancer
10/14/1999DE19815060A1 Pharmazeutische Präparate zur Therapie von Nebenwirkungen während und/oder nach einer GnRHa-Therapie Pharmaceutical preparations for the therapy of side effects during and / or after a GnRHa therapy
10/14/1999DE19814083A1 Verfahren zur Herstellung von transdermalen therapeutischen Systemen unter Verwendung von basischen Alkalimetallsalzen zur Umwandlung von Wirkstoffsalzen in die freien Basen A process for the production of transdermal therapeutic systems using basic alkali metal salts for the conversion of active substance salts into the free bases
10/14/1999DE19807426A1 Verfahren zur Behandlung von Erkrankungen oder Störungen des Innenohrs A method for the treatment of diseases or disorders of the inner ear
10/14/1999CA2328607A1 Antidiabetic agents
10/14/1999CA2327706A1 Methods for inhibiting mrp1
10/14/1999CA2327652A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/14/1999CA2327617A1 Methods for inhibiting mrp1
10/14/1999CA2327452A1 Methods for inhibiting mrp1
10/14/1999CA2327095A1 Compositions containing a combination of a creatine compound and a second agent
10/14/1999CA2326650A1 Azo and diaza dericatives and uses thereof in phototherapy
10/14/1999CA2326507A1 Methods and compositions for reducing uv-induced inhibition of collagen synthesis in human skin
10/14/1999CA2326185A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2326184A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2326143A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2326140A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2325995A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2325339A1 Dadd, death activator death domain protein
10/14/1999CA2325050A1 A novel nitroreductase and therapeutic uses therefor
10/14/1999CA2325007A1 Human galactosyl transferases
10/14/1999CA2324976A1 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof
10/14/1999CA2324868A1 Human oxidized ldl receptor
10/13/1999EP0949332A2 HSSCRG1 polypeptides
10/13/1999EP0948646A1 Methods for identifying genes essential to the growth of an organism
10/13/1999EP0948632A1 Methods for the characterization and selection of rna target motifs that bind compounds of pharmaceutical use
10/13/1999EP0948627A2 Glutathionylspermidine synthetase
10/13/1999EP0948622A1 Human mage-like protein
10/13/1999EP0948609A2 Llg polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
10/13/1999EP0948597A1 HUMAN MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MAdCAM-1) AND SPLICE VARIANTS THEREOF
10/13/1999EP0948510A1 Immunostimulatory nucleic acid molecules
10/13/1999EP0948360A1 Novel lipid compounds and compositions containing same used for the transfer of at least an active substance, in particular a polynucleotide, in a target cell and therapeutic use
10/13/1999EP0948355A1 Treatment of lupus nephritis with anti-cd40l compounds
10/13/1999EP0948349A1 Treatment of inner ear hair cells
10/13/1999EP0948348A1 Manipulation of non-terminally differentiated cells using the notch pathway
10/13/1999EP0948341A1 Phospholipid drug derivatives
10/13/1999EP0948335A1 Methods of treating or preventing cardiac arrhythmia
10/13/1999EP0948334A1 Method of treating prostatic diseases using active vitamin d analogues
10/13/1999EP0948333A1 Use of a combination of carbonic anhydrase inhibitors and prostaglandins for treating glaucoma
10/13/1999EP0948324A2 Methods and pharmaceutical compositions for inhibiting tumour cell growth
10/13/1999EP0948323A1 Protease-activated receptor 3 and uses thereof
10/13/1999EP0948308A1 Methods for treating skin pigmentation
10/13/1999EP0948256A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna
10/13/1999EP0672192B1 Method for inhibition of viral morphogenesis
10/13/1999EP0668854B1 Use of n-arylmethylene, ethylenediaminetriacetates n-arylmethylene iminodiacetates or n,n'-diarylmethylene ethylenediaminacetates for use in combatting oxidative stress
10/13/1999CN1231609A Antimycotic gel with active substance release
10/12/1999US5965711 A protein; anticarcinogenic/antiarthritic/antidiabetic agents; treatment of addison's and crohn's disease, multiple sclerosis, scleroderma, ulcers, respiratory disorders; fungicides, viricides, bactericides
10/12/1999US5965703 Bcl-x/bcl-2 associated death polypeptide; used for regulating apoptosis in treating acquired immune deficiency syndrome and neurodegenerative diseases; antiischemic agents
10/12/1999US5965618 Treatment of scar tissue using lipoic acid
10/12/1999US5965610 Mixture containing chlorhexidine gluconate and zinc gluconate
10/12/1999US5965606 Retinoid receptors, 2-fluoro-4-(2',2',4',4'-tetramethyl-8'-trifluoromethylchroman-6' -yl)carbamoyl benzoic acid for treating monocytic leukemia
10/12/1999US5965584 Pharmaceutical composition
10/12/1999US5965571 Cholinesterase inhibitors for treatment of Parkinson's disease
10/12/1999US5965551 Method of treating alopecia
10/12/1999US5965540 Antiinflammatory agent
10/12/1999US5965533 Atrial natriuretic peptide (ANP) as an additive to peritoneal dialysis solutions
10/12/1999US5965521 Pulsatile delivery of leptin receptor ligands
10/12/1999US5965423 A polypeptide; diagnosis of cirrhosis, multiple sclerosis, gastrointestinal disorders, respiratory disorders, acquired immune defiency syndrome; antiarthritic/antiischemic/ antiallergens/ antiproliferactive agents
10/12/1999US5965420 A protein which stimulates cell proliferation; treatment of bone loss due to osteoporosis; treat adult respiratory disease syndrome, parkinson'disease, huntington's disease; antiarthritic/anticarcinogenic agents; antiallergens
10/12/1999US5965416 Arginyl tRNA synthetase from staphyloccus aureus
10/12/1999US5965396 Human lymph node derived GTPase
10/12/1999US5965392 A nucleic acid molecule; treating obesity or anorexia
10/12/1999US5965373 Identifying enzyme inhibitors by combining a dimeric protein with a substrate, and a compound believed to be an inhibitor and determining activity of the protein on the substrate; diagnosis of epithelial cancer
10/12/1999US5965367 Purified bradykinin B1 receptor
10/12/1999US5965365 A human growth factor receptor binding gene; treatment and diagnosis of smooth muscle disorders; antiproliferative/ anticarcinogenic/antitumor agents
10/12/1999US5965152 Controlled release of miotic and mydriatic drugs in the anterior chamber
10/12/1999US5965133 Self-assembling multimeric nucleic acid constructs
10/12/1999US5965131 Galactosylated clearing agent binds to the primary binding site of the primary targeting species, and only non-bound primary targeting species is cleared, not bound species second site is not blocked by the clearing agent
10/12/1999US5965121 Compounds and compositions for delivering active agents
10/12/1999US5965119 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
10/12/1999CA2168732C Gelatin capsules containing a highly concentrated acetaminophen solution